Previous Page  29 / 37 Next Page
Information
Show Menu
Previous Page 29 / 37 Next Page
Page Background

Page 84

Notes:

conferenceseries

.com

Volume 9, Issue 9 (Suppl)

J Cancer Sci Ther, an open access journal

ISSN: 1948-5956

World Cancer 2017

October 19-21, 2017

25

th

WORLD CANCER CONFERENCE

October 19-21, 2017 | Rome, Italy

J Cancer Sci Ther 2017, 9:9(Suppl)

DOI: 10.4172/1948-5956-C1-112

Effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea

and vomiting in Chinese lung cancer patients

Dan Luo

1

and

Huaping Liu

2

1

University of Sydney, Australia

2

Peking Union Medical College, China

Background:

Behavioral techniques such as progressive muscle relaxation training are becoming increasingly important in

dealing with chemotherapy-induced nausea and vomiting.

Objective:

This study was designed to assess the effectiveness of progressive muscle relaxation training (PMRT) in reducing

the nausea and vomiting by highly emetogenic chemotherapy in lung cancer patients.

Methods:

72 chemotherapy-naive lung cancer patients participated and were divided into two groups. 36 patients in the

experimental group received PMRT 1 h before and after chemotherapy with cisplatin for 3 days, and daily thereafter for

another 4 days (totally 7 days). Patients received PMRT twice per day and each session lasted for 25 minutes. The instruments

used for data collection was MASCC Antiemesis Tool (MAT) which was used daily for the 7 post-chemotherapy days.

Results:

The use of PMRT considerably decreased the vomiting episodes and nausea intensity in the experimental group

compared with the control group in the delayed phase (P<0.01), whereas there were no differences in acute phase. Neither

nausea nor vomiting differed in incidents between the two groups in the acute and delayed phases .

Conclusion:

Such findings suggest that PMRT is a useful technique in the delayed phase to reduce nausea and vomiting by

highly emetogenic chemotherapy. Incorporating the interventions into the care plan can improve symptom management of

cancer patients who experience gastrointestinal side effects of chemotherapy.

dluo7794@uni.sydney.edu.au